| Stage | PRAA | % of rev | ECPG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $372M | 100.00% | $421M | 100.00% | ECPG ×1.13 |
| Gross profit | $302M | 81.09% | $301M | 71.58% | PRAA +9.5pp |
| Operating income | $153M | 41.19% | $187M | 44.42% | ECPG +3.2pp |
| Pre-tax income | $88M | 23.73% | $83M | 19.69% | PRAA +4.0pp |
| Net income | $59M | 15.84% | $64M | 15.21% | PRAA +0.6pp |
| Stage | PRAA | ECPG | Gap · A − B |
|---|---|---|---|
| Revenue | $372M100.00% | $421M100.00% | ECPG ×1.13 |
| Gross profit | 81.09%$302M | 71.58%$301M | PRAA +9.5pp |
| Operating income | 41.19%$153M | 44.42%$187M | ECPG +3.2pp |
| Pre-tax income | 23.73%$88M | 19.69%$83M | PRAA +4.0pp |
| Net income |
| 15.84%$59M |
| 15.21%$64M |
| PRAA +0.6pp |
No disclosed counterparties: PRAA, ECPG.